EC approves Bayer aflibercept solution for injection for wet AMD
Formulated as an iso-osmotic solution for intravitreal administration, the injection is a recombinant fusion protein comprising of portions of human VEGF receptors and extracellular domains fused to the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.